Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
10 studies found for:    pulmonary alveolar proteinosis
Show Display Options
RSS Create an RSS feed from your search for:
pulmonary alveolar proteinosis
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Prospective Trial of Rituximab for Primary Pulmonary Alveolar Proteinosis
Conditions: Pulmonary Alveolar Proteinosis;   Primary Disease
Intervention: Drug: rituximab
2 Recruiting Inhalation of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Autoimmune Pulmonary Alveolar Proteinosis (PAP)
Condition: Autoimmune Pulmonary Alveolar Proteinosis
Intervention: Drug: GM-CSF
3 Completed Inhaled Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in Hereditary Pulmonary Alveolar Proteinosis (PAP)
Condition: Hereditary Pulmonary Alveolar Proteinosis
Intervention: Drug: Leukine
4 Enrolling by invitation Whole Lung Lavage (WLL)/Inhaled Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) in Autoimmune Pulmonary Alveolar Proteinosis (PAP)
Condition: Pulmonary Alveolar Proteinosis
Interventions: Drug: GM-CSF [Leukine (Sargramostim)];   Procedure: WLL
5 Unknown  GM-CSF in Patients With Pulmonary Alveolar Proteinosis
Condition: Pulmonary Alveolar Proteinosis
Intervention: Drug: GM-CSF (granulocyte-macrophage colony-stimulating factor, sargramostim)
6 Recruiting Study of Subcutaneous Injection of Low-dose rhGM-CSF +/- WLL in PAP.
Condition: Pulmonary Alveolar Proteinosis
Interventions: Drug: rhGM-CSF;   Procedure: Whole Lung Lavage(WLL)
7 Recruiting Evaluation and Treatment Planning of Patients With PAP Using Thrive Ultra Short Echo Time MRI and CT
Condition: Pulmonary Alveolar Proteinosis (PAP).
Interventions: Device: MRI;   Radiation: Research CT if clinical one is complete before the pre lavage
8 Recruiting Rituximab for Anti-cytokine Autoantibody-Associated Diseases
Conditions: Anticytokine Autoantibody-Associated Diseases;   Disseminated Non-Tuberculous Mycobacteria;   Chronic Mucocutaneous Candidiasis;   Pulmonary Alveolar Proteinosis (PAP)
Intervention: Drug: Rituximab/Rituxan
9 Recruiting Natural History Study of GATA2 Deficiency and Related Disorders
Conditions: Myelodysplasia;   Monocytopenia;   B Cell Lymphopenia;   NK Cell Deficiency;   Warts
Intervention:
10 Recruiting Epidemiology of Surfactant Protein-B Deficiency
Conditions: Lung Diseases;   Respiratory Distress Syndrome, Newborn;   Pulmonary Surfactants
Intervention:

Indicates status has not been verified in more than two years